CL
GMED icon

Croft-Leominster’s Globus Medical GMED Stock Holding History

Croft-Leominster’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,600
Closed -$252K – 190
2014
Q4 		$252K Hold
10,600
– – 0.04% 149
2014
Q3 		$208K Buy
+10,600
New +$218K 0.04% 167

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Croft-Leominster's GMED Position: Q1 2015 in Review

Croft-Leominster sold out of Globus Medical (GMED) in Q1 2015, closing a stake of 10,600 shares — an estimated $252K sold.

Croft-Leominster first reported a position in GMED in Q3 2014 and held it in 2 quarters. The position peaked at $252K in Q4 2014. 179 funds tracked by Wall St. Rank hold GMED as of Q1 2015.

  • Croft-Leominster reported no remaining Globus Medical position as of Q1 2015 after selling out during the quarter.
  • Croft-Leominster sold 10,600 Globus Medical shares in Q1 2015, an estimated $252K.
  • Croft-Leominster first reported a position in Globus Medical in Q3 2014 and held it in 2 quarters.
  • Croft-Leominster's Globus Medical position peaked at $252K in Q4 2014.
  • 179 funds tracked by Wall St. Rank held Globus Medical as of Q1 2015.

Based on Croft-Leominster's 13F filing for Q1 2015, filed 14 May 2015.